Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Markus Zeitlinger

Showing results (321-330 of 352) with videos related to

Pageof 36
Sort By:
European Journal of Clinical Pharmacology|May 10, 2021
A phase I study assessing the safety, tolerability, immunogenicity, and low-density lipoprotein cholesterol-lowering activity of immunotherapeutics targeting PCSK9Markus Zeitlinger, Martin Bauer, Roman Reindl-Schwaighofer, et al.
Clinical Pharmacology and Therapeutics|September 24, 2017
Influence of OATPs on Hepatic Disposition of Erlotinib Measured With Positron Emission TomographyMartin Bauer, Akihiro Matsuda, Beatrix Wulkersdorfer, et al.
The Journal of Antimicrobial Chemotherapy|August 26, 2022
Binding of temocillin to plasma proteins in vitro and in vivo: the importance of plasma protein levels in different populations and of co-medicationsPerrin Ngougni Pokem, Peter Matzneller, Steven Vervaeke, et al.
Frontiers in Immunology|August 28, 2023
Direct endothelial ENaC activation mitigates vasculopathy induced by SARS-CoV2 spike proteinMaritza J Romero, Qian Yue, Bhupesh Singla, et al.
American Journal of Respiratory and Critical Care Medicine|May 7, 2026
Effects of an early restrictive versus liberal fluid strategy on long-term patient-centered outcomes in sepsis-induced hypotension (SHAMROC): an open-label, randomized controlled trialAnselm Jorda, Georg Gelbenegger, Nathan I Shapiro, et al.
The Journal of Infection|January 5, 2025
Immunogenicity, safety, and reactogenicity of concomitant administration of the novavax vaccine against Omicron XBB.1.5 (NVX-CoV2601) and a 20-valent pneumococcal conjugate vaccine in adults aged ≥60 years: A randomised, double-blind, placebo-controlled, non-inferiority trialAnselm Jorda, Marlene Prager, Lena Pracher, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|December 12, 2022
Reduced immunogenicity of BNT162b2 booster vaccination in combination with a tetravalent influenza vaccination: results of a prospective cohort study in 838 health workersHelga Radner, Daniela Sieghart, Anselm Jorda, et al.
The Journal of Infectious Diseases|August 29, 2009
A cell culture (Vero)-derived H5N1 whole-virus vaccine induces cross-reactive memory responsesHartmut J Ehrlich, Markus Müller, Sandor Fritsch, et al.
The Journal of Antimicrobial Chemotherapy|April 24, 2024
First-in-human study of alpibectir (BVL-GSK098), a novel potent anti-TB drugMichel Pieren, Ana Abáigar Gutiérrez-Solana, Rosa María Antonijoan Arbós, et al.
Clinical and Vaccine Immunology : CVI|September 5, 2014
A Novel multivalent OspA vaccine against Lyme borreliosis is safe and immunogenic in an adult population previously infected with Borrelia burgdorferi sensu latoNina Wressnigg, P Noel Barrett, Eva-Maria Pöllabauer, et al.
Pageof 36

Showing results (321-330 of 352) with videos related to

Sort By:
Pageof 36
European Journal of Clinical Pharmacology|May 10, 2021
A phase I study assessing the safety, tolerability, immunogenicity, and low-density lipoprotein cholesterol-lowering activity of immunotherapeutics targeting PCSK9Markus Zeitlinger, Martin Bauer, Roman Reindl-Schwaighofer, et al.
Clinical Pharmacology and Therapeutics|September 24, 2017
Influence of OATPs on Hepatic Disposition of Erlotinib Measured With Positron Emission TomographyMartin Bauer, Akihiro Matsuda, Beatrix Wulkersdorfer, et al.
The Journal of Antimicrobial Chemotherapy|August 26, 2022
Binding of temocillin to plasma proteins in vitro and in vivo: the importance of plasma protein levels in different populations and of co-medicationsPerrin Ngougni Pokem, Peter Matzneller, Steven Vervaeke, et al.
Frontiers in Immunology|August 28, 2023
Direct endothelial ENaC activation mitigates vasculopathy induced by SARS-CoV2 spike proteinMaritza J Romero, Qian Yue, Bhupesh Singla, et al.
American Journal of Respiratory and Critical Care Medicine|May 7, 2026
Effects of an early restrictive versus liberal fluid strategy on long-term patient-centered outcomes in sepsis-induced hypotension (SHAMROC): an open-label, randomized controlled trialAnselm Jorda, Georg Gelbenegger, Nathan I Shapiro, et al.
The Journal of Infection|January 5, 2025
Immunogenicity, safety, and reactogenicity of concomitant administration of the novavax vaccine against Omicron XBB.1.5 (NVX-CoV2601) and a 20-valent pneumococcal conjugate vaccine in adults aged ≥60 years: A randomised, double-blind, placebo-controlled, non-inferiority trialAnselm Jorda, Marlene Prager, Lena Pracher, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|December 12, 2022
Reduced immunogenicity of BNT162b2 booster vaccination in combination with a tetravalent influenza vaccination: results of a prospective cohort study in 838 health workersHelga Radner, Daniela Sieghart, Anselm Jorda, et al.
The Journal of Infectious Diseases|August 29, 2009
A cell culture (Vero)-derived H5N1 whole-virus vaccine induces cross-reactive memory responsesHartmut J Ehrlich, Markus Müller, Sandor Fritsch, et al.
The Journal of Antimicrobial Chemotherapy|April 24, 2024
First-in-human study of alpibectir (BVL-GSK098), a novel potent anti-TB drugMichel Pieren, Ana Abáigar Gutiérrez-Solana, Rosa María Antonijoan Arbós, et al.
Clinical and Vaccine Immunology : CVI|September 5, 2014
A Novel multivalent OspA vaccine against Lyme borreliosis is safe and immunogenic in an adult population previously infected with Borrelia burgdorferi sensu latoNina Wressnigg, P Noel Barrett, Eva-Maria Pöllabauer, et al.
Pageof 36